In line with our in vitro data, direct analyses of IFNγR1KO tumor cells (CD45−) did not show upregulation of PD-L1 (Fig. 1i) and MHC II (Fig. 1j) upon anti-CTLA-4, in contrast to marked upregulation in scrambled control melanoma cells. The gene discussed is CTLA4; the disease is melanoma.